372 related articles for article (PubMed ID: 34740359)
41. Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure.
Jug B; Sebestjen M; Sabovic M; Pohar M; Keber I
Wien Klin Wochenschr; 2009; 121(21-22):700-6. PubMed ID: 19998011
[TBL] [Abstract][Full Text] [Related]
42. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
[TBL] [Abstract][Full Text] [Related]
43. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
[TBL] [Abstract][Full Text] [Related]
44. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS
Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821
[TBL] [Abstract][Full Text] [Related]
45. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
[TBL] [Abstract][Full Text] [Related]
46. Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis.
Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29275373
[TBL] [Abstract][Full Text] [Related]
47. N-Terminal B-type Natriuretic Peptide in Heart Failure.
Richards AM
Heart Fail Clin; 2018 Jan; 14(1):27-39. PubMed ID: 29153198
[TBL] [Abstract][Full Text] [Related]
48. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
Hamano K; Nakadaira I; Suzuki J; Gonai M
Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
[TBL] [Abstract][Full Text] [Related]
49. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
50. Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Diaz R; Dickstein K; Gerstein HC; Køber L; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Pfeffer MA
Circulation; 2017 Oct; 136(16):1560-1562. PubMed ID: 29038210
[No Abstract] [Full Text] [Related]
51. Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction.
Pastormerlo LE; Mammini C; Giannoni A; Valleggi A; Prontera C; Gabutti A; Poletti R; Padeletti L; Emdin M; Passino C
J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):423-30. PubMed ID: 25083720
[TBL] [Abstract][Full Text] [Related]
52. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
53. [Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP].
Luchner A; von Haehling S; Holubarsch C; Keller T; Knebel F; Zugck C; Laufs U
Dtsch Med Wochenschr; 2017 Mar; 142(5):346-355. PubMed ID: 28282683
[TBL] [Abstract][Full Text] [Related]
54. Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.
Tamaki S; Yamada T; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Fujikawa K; Hata M; Fujita Y; Umayahara Y; Taniuchi S; Sanada S; Shintani A; Fukunami M
Circ Heart Fail; 2021 Mar; 14(3):e007048. PubMed ID: 33663235
[TBL] [Abstract][Full Text] [Related]
55. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.
Choi EY; Bahrami H; Wu CO; Greenland P; Cushman M; Daniels LB; Almeida AL; Yoneyama K; Opdahl A; Jain A; Criqui MH; Siscovick D; Darwin C; Maisel A; Bluemke DA; Lima JA
Circ Heart Fail; 2012 Nov; 5(6):727-34. PubMed ID: 23032197
[TBL] [Abstract][Full Text] [Related]
56. Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level.
Kishimoto I; Makino H; Ohata Y; Tamanaha T; Tochiya M; Kada A; Ishihara M; Anzai T; Shimizu W; Yasuda S; Ogawa H
Diabetes Res Clin Pract; 2014 May; 104(2):257-65. PubMed ID: 24629410
[TBL] [Abstract][Full Text] [Related]
57. NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure.
Parovic M; Okwose NC; Bailey K; Velicki L; Fras Z; Seferovic PM; MacGowan GA; Jakovljevic DG
ESC Heart Fail; 2019 Apr; 6(2):449-454. PubMed ID: 30788904
[TBL] [Abstract][Full Text] [Related]
58. Hemoglobin Concentration Influences N-Terminal Pro B-Type Natriuretic Peptide Levels in Hospitalized Older Adults with and without Heart Failure.
Lelli D; Antonelli Incalzi R; Pedone C
J Am Geriatr Soc; 2017 Nov; 65(11):2369-2373. PubMed ID: 28556898
[TBL] [Abstract][Full Text] [Related]
59. Evidence based application of BNP/NT-proBNP testing in heart failure.
Don-Wauchope AC; McKelvie RS
Clin Biochem; 2015 Mar; 48(4-5):236-46. PubMed ID: 25448029
[TBL] [Abstract][Full Text] [Related]
60. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
